Delivery Order SPE2DR25D2212-SPE2DR26FB9ME
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of INBRIJA 42 mg inhalation capsules (60-count units) with a ceiling value of $1,941.36. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures and scheduled for completion by May 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency has awarded a delivery order valued at $1,294.24 to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60-count), with an ultimate completion date of November 26, 2025. This non-set-aside competitive award was issued on November 4, 2025, under firm fixed pricing terms. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,941.36 delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60-count package) on September 15, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price, competitively awarded contract (non-set-aside) will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- This delivery order, valued at $3,882.72, awards AmerisourceBergen Drug Corp the supply of INBRIJA 42 MG inhalation capsules (60-count units) under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain. The award was made on September 16, 2025, without a set-aside designation, indicating the contract was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Inbrija 42 mg inhalation capsules (60-count package) under a firm fixed-price contract with a ceiling value of $1,879.50. This competitive award, with no set-aside designation, utilizes the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026....
- The U.S. Defense Logistics Agency (DLA) awarded a $1,251.00 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564542915 INBRIJA 42 MG INHALATION CAP 60S. The contract has an ultimate completion date of May 30, 2024. This order is placed under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC allows the DLA to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60-count units) with a ceiling value of $1,879.50. This non-set-aside, firm fixed-price delivery order was competitively awarded on November 25, 2025, with an ultimate completion date of December 17, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,502 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,694,800 INBRIJA 42 MG INHALATION CAP 60S. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs...
- This is a $1,294.24 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INBRIJA 42 MG INHALATION CAP 60S. The contract has an ultimate completion date of July 21, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,876.50 firm-fixed-price delivery order is for the supply of INBRIJA 42 MG INHALATION CAPSULES. This contract has an ultimate completion date of August 8, 2024 and is not set aside for any specific business category. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DR25D2212Indefinite Delivery Contract
- SPE2DR25D2212-SPE2DR26FB9MEDelivery Order
The Defense Logistics Agency awarded a $3,132.50 delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60-count units) with a firm fixed price structure. The contract, which is not set-aside, was awarded on December 18, 2025, with an ultimate completion date of January 12, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. This award falls under AmerisourceBergen Drug Corp's comprehensive $999,999,999.00 indefinite delivery contract with the Defense Logistics Agency, designated as SPE2DX and running through December 2026. The prime contract serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitively awarded contracts involving firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 12/17/25 |